ATOSSA THERAPEUTICS, INC. Depreciation
ATOSSA THERAPEUTICS, INC. (ATOS) reported Depreciation of $8.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-07
- ATOSSA THERAPEUTICS, INC. depreciation for the quarter ending 2026-06-30 was $4.00K, a 0.00% change year-over-year.
- ATOSSA THERAPEUTICS, INC. depreciation for the quarter ending 2026-03-31 was $4.00K, a 0.00% change year-over-year.
- ATOSSA THERAPEUTICS, INC. depreciation for the quarter ending 2025-12-31 was $4.00K, a 0.00% change year-over-year.
- ATOSSA THERAPEUTICS, INC. depreciation for the quarter ending 2025-09-30 was $4.00K, a 0.00% change year-over-year.
- ATOSSA THERAPEUTICS, INC. depreciation for fiscal 2025 was $16.00K, a 5.88% decline from fiscal 2024.
- ATOSSA THERAPEUTICS, INC. depreciation for fiscal 2024 was $17.00K, a 26.09% decline from fiscal 2023.
- ATOSSA THERAPEUTICS, INC. depreciation for fiscal 2023 was $23.00K, a 187.50% increase from fiscal 2022.
- ATOSSA THERAPEUTICS, INC. depreciation for fiscal 2022 was $8.00K, a 20.00% decline from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 3 month as first filed | Depreciation 6 month | Depreciation 6 month as first filed | Depreciation 9 month | Depreciation 12 month | Depreciation 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $8.00K 10-Q · filed 2026-08-07 | $12.00K derived: sum of 3 quarters · filed 2026-08-07 | $16.00K derived: sum of 4 quarters · filed 2026-08-07 | |||
| 2026-03-31 | $4.00K 10-Q · filed 2026-05-08 | $8.00K derived: sum of 2 quarters · filed 2026-05-08 | $12.00K derived: sum of 3 quarters · filed 2026-05-08 | $16.00K derived: sum of 4 quarters · filed 2026-08-07 | |||
| 2025-12-31 | $4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $8.00K derived: sum of 2 quarters · filed 2026-03-25 | $12.00K derived: sum of 3 quarters · filed 2026-08-07 | $16.00K 10-K · filed 2026-03-25 | |||
| 2025-09-30 | $4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $8.00K derived: sum of 2 quarters · filed 2026-08-07 | $12.00K 10-Q · filed 2025-11-12 | $16.00K derived: sum of 4 quarters · filed 2026-08-07 | |||
| 2025-06-30 | $4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $8.00K 10-Q · filed 2026-08-07 | $12.00K derived: sum of 3 quarters · filed 2026-08-07 | $16.00K derived: sum of 4 quarters · filed 2026-08-07 | |||
| 2025-03-31 | $4.00K 10-Q · filed 2026-05-08 | $8.00K derived: sum of 2 quarters · filed 2026-05-08 | $12.00K derived: sum of 3 quarters · filed 2026-05-08 | $16.00K derived: sum of 4 quarters · filed 2026-05-08 | |||
| 2024-12-31 | $4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $8.00K derived: sum of 2 quarters · filed 2026-03-25 | $12.00K derived: sum of 3 quarters · filed 2026-03-25 | $17.00K 10-K · filed 2026-03-25 | |||
| 2024-09-30 | $4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $8.00K derived: sum of 2 quarters · filed 2025-11-12 | $13.00K 10-Q · filed 2025-11-12 | $27.00K derived: sum of 4 quarters · filed 2025-11-12 | |||
| 2024-06-30 | $4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $9.00K 10-Q · filed 2025-08-12 | $23.00K derived: sum of 3 quarters · filed 2025-08-12 | $26.00K derived: sum of 4 quarters · filed 2025-08-12 | |||
| 2024-03-31 | $5.00K 10-Q · filed 2025-05-13 | $19.00K derived: sum of 2 quarters · filed 2025-05-13 | $22.00K derived: sum of 3 quarters · filed 2025-05-13 | $25.00K derived: sum of 4 quarters · filed 2025-05-13 | |||
| 2023-12-31 | $14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-25 | $17.00K derived: sum of 2 quarters · filed 2025-03-25 | $20.00K derived: sum of 3 quarters · filed 2025-03-25 | $23.00K 10-K · filed 2025-03-25 | |||
| 2023-09-30 | $3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $6.00K derived: sum of 2 quarters · filed 2024-11-12 | $9.00K 10-Q · filed 2024-11-12 | ||||
| 2023-06-30 | $3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $6.00K 10-Q · filed 2024-08-12 | |||||
| 2023-03-31 | $3.00K 10-Q · filed 2024-05-13 | ||||||
| 2022-12-31 | $8.00K 10-K · filed 2024-04-01 | ||||||
| 2021-12-31 | $10.00K 10-K · filed 2022-02-28 | ||||||
| 2020-12-31 | $19.00K 10-K · filed 2022-02-28 | ||||||
| 2019-12-31 | $22.00K 10-K · filed 2021-03-31 | ||||||
| 2018-12-31 | $14.00K 10-K · filed 2020-03-26 | $14.39K 10-K · filed 2019-03-28 | |||||
| 2018-03-31 | $2.73K 10-Q · filed 2018-05-14 | $5.69K derived: sum of 2 quarters · filed 2019-03-28 | $10.25K derived: sum of 3 quarters · filed 2019-03-28 | $19.02K derived: sum of 4 quarters · filed 2019-03-28 | |||
| 2017-12-31 | $2.97K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-28 | $7.52K derived: sum of 2 quarters · filed 2019-03-28 | $16.30K derived: sum of 3 quarters · filed 2019-03-28 | $25.96K 10-K · filed 2019-03-28 | |||
| 2017-09-30 | $4.55K 10-Q · filed 2017-11-13 | $13.33K derived: sum of 2 quarters · filed 2017-11-13 | $22.99K 10-Q · filed 2017-11-13 | $56.60K derived: sum of 4 quarters · filed 2018-05-14 | |||
| 2017-06-30 | $8.77K 10-Q · filed 2017-08-14 | $18.43K 10-Q · filed 2017-08-14 | $52.04K derived: sum of 3 quarters · filed 2018-05-14 | $81.74K derived: sum of 4 quarters · filed 2018-05-14 | |||
| 2017-03-31 | $9.66K 10-Q · filed 2018-05-14 | $43.27K derived: sum of 2 quarters · filed 2018-05-14 | $72.97K derived: sum of 3 quarters · filed 2018-05-14 | $105.70K derived: sum of 4 quarters · filed 2018-05-14 | |||
| 2016-12-31 | $33.61K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $63.30K derived: sum of 2 quarters · filed 2018-03-08 | $96.04K derived: sum of 3 quarters · filed 2018-03-08 | $125.66K 10-K · filed 2018-03-08 | |||
| 2016-09-30 | $29.70K 10-Q · filed 2017-11-13 | $62.43K derived: sum of 2 quarters · filed 2017-11-13 | $92.05K 10-Q · filed 2017-11-13 | $65.09K derived: sum of 4 quarters · filed 2017-11-13 | |||
| 2016-06-30 | $32.73K 10-Q · filed 2017-08-14 | $62.35K 10-Q · filed 2017-08-14 | $35.39K derived: sum of 3 quarters · filed 2017-08-14 | $68.01K derived: sum of 4 quarters · filed 2017-08-14 | |||
| 2016-03-31 | $26.62K 10-Q · filed 2017-05-11 | $29.62K 10-Q/A · filed 2017-03-21 | $2.65K derived: sum of 2 quarters · filed 2017-05-11 | $35.27K derived: sum of 3 quarters · filed 2017-05-11 | $48.55K derived: sum of 4 quarters · filed 2017-05-11 | ||
| 2015-12-31 | -$23.96K derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2017-03-21 | $8.65K derived: sum of 2 quarters · filed 2017-03-21 | $21.93K derived: sum of 3 quarters · filed 2017-03-21 | $73.09K 10-K/A · filed 2017-03-21 | |||
| 2015-09-30 | $32.62K 10-Q/A · filed 2017-03-21 | $45.90K derived: sum of 2 quarters · filed 2017-03-21 | $97.06K 10-Q/A · filed 2017-03-21 | $138.39K derived: sum of 4 quarters · filed 2017-03-21 | |||
| 2015-06-30 | $13.28K 10-Q/A · filed 2017-03-21 | $63.44K 10-Q/A · filed 2017-03-21 | $105.77K derived: sum of 3 quarters · filed 2017-03-21 | $130.42K derived: sum of 4 quarters · filed 2017-03-21 | |||
| 2015-03-31 | $13.28K 10-Q/A · filed 2017-03-21 | $30.80K 10-Q · filed 2015-05-13 | $92.50K derived: sum of 2 quarters · filed 2017-03-21 | $117.14K derived: sum of 3 quarters · filed 2017-03-21 | $137.00K derived: sum of 4 quarters · filed 2017-03-21 | ||
| 2014-12-31 | $79.22K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-30 | $103.86K derived: sum of 2 quarters · filed 2015-03-30 | $123.72K derived: sum of 3 quarters · filed 2015-03-30 | $144.90K 10-K · filed 2015-03-30 | |||
| 2014-09-30 | $24.64K 10-Q · filed 2014-11-12 | $44.51K derived: sum of 2 quarters · filed 2014-11-12 | $65.68K 10-Q · filed 2014-11-12 | $85.80K derived: sum of 4 quarters · filed 2015-05-13 | |||
| 2014-06-30 | $19.86K 10-Q · filed 2014-08-12 | $41.03K 10-Q · filed 2014-08-12 | $61.16K derived: sum of 3 quarters · filed 2015-05-13 | $88.32K derived: sum of 4 quarters · filed 2015-05-13 | |||
| 2014-03-31 | $21.17K 10-Q · filed 2015-05-13 | $41.29K derived: sum of 2 quarters · filed 2015-05-13 | $68.46K derived: sum of 3 quarters · filed 2015-05-13 | $99.13K derived: sum of 4 quarters · filed 2015-05-13 | |||
| 2013-12-31 | $20.12K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-30 | $47.29K derived: sum of 2 quarters · filed 2015-03-30 | $77.95K derived: sum of 3 quarters · filed 2015-03-30 | $82.97K 10-K · filed 2015-03-30 | |||
| 2013-09-30 | $27.16K 10-Q · filed 2014-11-12 | $57.83K derived: sum of 2 quarters · filed 2014-11-12 | $62.85K 10-Q · filed 2014-11-12 | $74.81K derived: sum of 4 quarters · filed 2014-11-12 | |||
| 2013-06-30 | $30.67K 10-Q · filed 2014-08-12 | $35.54K 10-Q · filed 2014-08-12 | $35.54K 10-Q · filed 2013-08-14 | $47.65K derived: sum of 3 quarters · filed 2014-08-12 | $51.97K derived: sum of 4 quarters · filed 2014-08-12 | ||
| 2013-03-31 | $4.87K 10-Q · filed 2014-05-14 | $16.98K derived: sum of 2 quarters · filed 2014-05-14 | $21.30K derived: sum of 3 quarters · filed 2014-05-14 | $25.63K derived: sum of 4 quarters · filed 2014-05-14 | |||
| 2012-12-31 | $12.11K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27 | $16.43K derived: sum of 2 quarters · filed 2014-03-27 | $20.76K derived: sum of 3 quarters · filed 2014-03-27 | $25.08K 10-K · filed 2014-03-27 | |||
| 2012-09-30 | $4.32K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $8.65K derived: sum of 2 quarters · filed 2013-11-12 | $12.97K 10-Q · filed 2013-11-12 | $12.97K derived: sum of 4 quarters · filed 2013-11-12 | |||
| 2012-06-30 | $4.32K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | $8.65K 10-Q · filed 2013-08-14 | $8.65K derived: sum of 3 quarters · filed 2013-08-14 | ||||
| 2012-03-31 | $4.32K 10-Q · filed 2013-05-15 | $4.32K derived: sum of 2 quarters · filed 2013-05-15 | |||||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q/A 9 month · filed 2013-03-28 | $3.92K 10-K · filed 2013-03-28 | |||||
| 2011-09-30 | $3.92K 10-Q/A · filed 2013-01-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |